Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism
Author(s) -
Rodolfo Savica,
Brandon R. Grossardt,
James H. Bower,
J. Eric Ahlskog,
Bradley F. Boeve,
Jonathan GraffRadford,
Walter A. Rocca,
Michelle M. Mielke
Publication year - 2017
Publication title -
jama neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.298
H-Index - 231
eISSN - 2168-6157
pISSN - 2168-6149
DOI - 10.1001/jamaneurol.2017.0603
Subject(s) - rochester epidemiology project , synucleinopathies , parkinsonism , dementia , medicine , dementia with lewy bodies , population , epidemiology , medical record , disease , pediatrics , parkinson's disease , alpha synuclein , population based study , environmental health
To our knowledge, a comprehensive study of the survival and causes of death of persons with synucleinopathies compared with the general population has not been conducted. Understanding the long-term outcomes of these conditions may inform patients and caregivers of the expected disease duration and may help with care planning.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom